THE ULTIMATE GUIDE TO FENTANYL WIRKSTOFF

Coadministration of pexidartinib (a CYP3A4 inducer) with delicate CYP3A substrates could result in major therapeutic failures. If concomitant use is unavoidable, increase the CYP3A substrate dosage in accordance with authorised product labeling.lumacaftor/ivacaftor will lower the level or effect of fentanyl by affecting hepatic/intestinal enzyme CY